According to latest research report published by MarketsandMarkets, the Europe Sleep Apnea Devices Market report by Type, Therapeutic (PAP (CPAP, APAP, BPAP) Facial Interfaces, Oral Appliances, Accessories), Diagnostic (Psg, Oximeter, Actigraphy Systems), End User (Sleep Laboratories & Hospitals, Home Care Settings) & Region - Global Forecast to 2028, is expected to grow at a CAGR of 6.5% from 2023 to 2028. The growth of the market is attributed to the increasing prevalence of sleep apnea in the region, rising awareness about the condition, and government initiatives to promote the use of sleep apnea devices.
Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=719
In Europe, the prevalence of sleep apnea is estimated to be
around 10% of the adult population.
The
number of people with sleep apnea is expected to increase due to the aging
population and the rising prevalence of obesity. The governments of several
European countries have launched several initiatives to promote the use of sleep
apnea devices, such as subsidies for the purchase of devices and awareness
campaigns.
The
sleep apnea devices market in Europe is segmented by type, end-user, and
distribution channel. By type, the market is segmented into continuous positive
airway pressure (CPAP) devices, oral appliances, and other devices. CPAP
devices are the most commonly used type of sleep apnea devices. Oral appliances
are less effective than CPAP devices, but they are more comfortable to use.
Other devices include bilevel positive airway pressure (BiPAP) devices and
adjustable pressure ventilation (APV) devices.
By
end-user, the market is segmented into hospitals, clinics, and homecare
settings. Hospitals are the largest end-user segment of the market. Clinics and
homecare settings are expected to grow at a faster pace than hospitals due to
the increasing adoption of home-based sleep apnea treatment.
By
distribution channel, the market is segmented into direct sales and indirect
sales. Direct sales are the largest distribution channel of the market.
Indirect sales are expected to grow at a faster pace than direct sales due to
the increasing number of distributors and retailers selling sleep apnea
devices.
The
key players in the sleep apnea devices market in Europe include ResMed, Philips
Healthcare, Fisher & Paykel Healthcare, and SomnoMed. These players are
focusing on expanding their product portfolio, investing in research and
development, and acquiring smaller players to strengthen their market position.
Here are some of the factors that are driving the growth of the
sleep apnea devices market in Europe:
- Increasing
prevalence of sleep apnea
- Rising
awareness about sleep apnea
- Government
initiatives to promote the use of sleep apnea devices
- Growing
adoption of home-based sleep apnea treatment
- Increasing
number of distributors and retailers selling sleep apnea devices
Here are some of the challenges that are hindering the growth of
the sleep apnea devices market in Europe:
- High cost
of sleep apnea devices
- Lack of
awareness about sleep apnea
- Inadequate
reimbursement for sleep apnea devices
- Side
effects of sleep apnea devices
Overall,
the sleep apnea devices market in Europe is expected to grow at a healthy pace
in the coming years. The growth of the market will be driven by the increasing
prevalence of sleep apnea, rising awareness about the condition, and government
initiatives to promote the use of sleep apnea devices.
No comments:
Post a Comment